Evidence map›Paper›PMID 19837917›Full record

ArticleThe Journal of clinical endocrinology and metabolism2009

Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families.

Oscar Rubio-Cabezas, Ann-Marie Patch, Jayne A L Minton, Sarah E Flanagan, Emma L Edghill, Khalid Hussain, Amina Balafrej, Asma Deeb, Charles R Buchanan, Ian G Jefferson and 4 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Neonatal and early-onset diabetes in Ukraine: Atypical features and mortality.Diabetic medicine : a journal of the British Diabetic Association · 2023
    Article
  13. Article
  14. Growth and development in monogenic forms of neonatal diabetes.Current opinion in endocrinology, diabetes, and obesity · 2022
    Review
  15. Wolcott-Rallison syndrome: a case series of three patients.Pediatric endocrinology, diabetes, and metabolism · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Neonatal Diabetes Mellitus: Novel Mutations.Indian journal of pediatrics · 2021
    Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
    Tukkahrman, Doga [corrected to Turkkahraman, Doga]
5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Oscar Rubio-CabezasInstitute of Biomedical and Clinical Science, Peninsula Medical School, Exeter EX2 5DW, United Kingdom.
Ann-Marie Patch
Jayne A L Minton
Sarah E Flanagan
Emma L Edghill
Khalid Hussain
Amina Balafrej
Asma Deeb
Charles R Buchanan
Ian G Jefferson
Angham Mutair
Neonatal Diabetes International Collaborative Group
Andrew T Hattersley
Sian Ellard
Peninsula College of Medicine and Dentistry · GBHospital Infantil Universitario Niño Jesús · ESImperial College London Diabetes Centre · AEKing Abdulaziz Medical City · SANational Health Service · GBShaikh Khalifa Medical City · AEUniversity College London · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

CONTEXT AND

objectiveMutations in EIF2AK3 cause Wolcott-Rallison syndrome (WRS), a rare recessive disorder characterized by early-onset diabetes, skeletal abnormalities, and liver dysfunction. Although early diagnosis is important for clinical management, genetic testing is generally performed after the full clinical picture develops. We aimed to identify patients with WRS before any other abnormalities apart from diabetes are present and study the overall frequency of WRS among patients with permanent neonatal diabetes. RESEARCH DESIGN AND

methodsThe coding regions of EIF2AK3 were sequenced in 34 probands with infancy-onset diabetes with a clinical phenotype suggestive of WRS (n = 28) or homozygosity at the WRS locus (n = 6).

resultsTwenty-five probands (73.5%) were homozygous or compound heterozygous for mutations in EIF2AK3. Twenty of the 26 mutations identified were novel. Whereas a diagnosis of WRS was suspected before genetic testing in 22 probands, three patients with apparently isolated diabetes were diagnosed after identifying a large homozygous region encompassing EIF2AK3. In contrast to nonconsanguineous pedigrees, mutations in EIF2AK3 are the most common known genetic cause of diabetes among patients born to consanguineous parents (24 vs. < 2%). Age at diabetes onset and birth weight might be used to prioritize genetic testing in the latter group.

conclusionsWRS is the most common cause of permanent neonatal diabetes mellitus in consanguineous pedigrees. In addition to testing patients with a definite clinical diagnosis, EIF2AK3 should be tested in patients with isolated neonatal diabetes diagnosed after 3 wk of age from known consanguineous families, isolated populations, or countries in which inbreeding is frequent.

Indexed as

ConsanguinityMutationAge of OnsetCongenital AbnormalitiesDiabetes MellitusDNAeIF-2 KinaseFemaleGene AmplificationGenetic Diseases, InbornGenotypeHomozygoteHumansInfant, NewbornLiverMaleDNAEIF2AK3 protein, humaneIF-2 Kinase

Identifiers

PMID19837917
PMCPMC2775655
OpenAlexW2052100581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.